News
Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following ...
Hypoxia may be a promising therapy path to address Parkinson's neurodegeneration caused by excessive oxygen levels in the brain.
Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...
A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.
In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results